One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis
Joanna Chikwe, Patrick O’Gara, Stephen Fremes, Thoralf M. Sundt, David H. Adams
doi : 10.1016/j.jacc.2021.04.062
Volume 78, Issue 1, 6 July 2021, Pages 1-9
Transcatheter edge-to-edge (TEER) mitral repair may be complicated by residual or recurrent mitral regurgitation. An increasing need for surgical reintervention has been reported, but operative outcomes are ill defined.
Failed Mitral TEER: Are There Lessons for Decision Making??
Subodh Verma, David A. Latter, Robert O. Bonow
doi : 10.1016/j.jacc.2021.04.086
Volume 78, Issue 1, 6 July 2021, Pages 10-13
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
John W. Eikelboom, Deepak L. Bhatt, Keith A.A. Fox, Jacqueline Bosch, Salim Yusuf
doi : 10.1016/j.jacc.2021.04.083
Volume 78, Issue 1, 6 July 2021, Pages 14-23
The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared with 100 mg aspirin once daily reduces major adverse cardiovascular (CV) events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
Antithrombotic Therapy to Reduce Mortality in Patients With Atherosclerosis: 2 Pathways to a Single Goal?
Jonathan L. Halperin, Huazhen Chen, Jeffrey W. Olin
doi : 10.1016/j.jacc.2021.05.005
Volume 78, Issue 1, 6 July 2021, Pages 24-26
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Hideyuki Kawashima, Patrick W. Serruys, Masafumi Ono, Hironori Hara, Yoshinobu Onuma
doi : 10.1016/j.jacc.2021.04.087
Volume 78, Issue 1, 6 July 2021, Pages 27-38
The benefit of optimal medical therapy (OMT) on 5-year outcomes in patients with 3-vessel disease and/or left main disease after percutaneous coronary intervention or coronary artery bypass grafting (CABG) was demonstrated in the randomized SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial.
Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy?
William E. Boden, Bernard J. Gersh
doi : 10.1016/j.jacc.2021.04.088
Volume 78, Issue 1, 6 July 2021, Pages 39-41
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure
Bing Yu, Mary B. Roberts, Laura M. Raffield, Seyedeh Maryam Zekavat, Charles B. Eaton
doi : 10.1016/j.jacc.2021.04.085
Volume 78, Issue 1, 6 July 2021, Pages 42-52
Age-related clonal hematopoiesis of indeterminate potential (CHIP), defined as clonally expanded leukemogenic sequence variations (particularly in DNMT3A, TET2, ASXL1, and JAK2) in asymptomatic individuals, is associated with cardiovascular events, including recurrent heart failure (HF).
Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium?
José J. Fuster
doi : 10.1016/j.jacc.2021.04.084
Volume 78, Issue 1, 6 July 2021, Pages 53-55
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8
Rishi Caleyachetty, Thomas Littlejohns, Ben Lacey, Jelena Be?evi?,Naomi Allen
doi : 10.1016/j.jacc.2021.03.342
Volume 78, Issue 1, 6 July 2021, Pages 56-65
An increasing number of people are now living with cardiovascular disease (CVD), with concomitant CVD-related hospitalizations, operations, and prescriptions. To ultimately deliver optimal cardiovascular care, access to population-based biobanks with data on multiomics, phenotypes, and lifestyle risk factors are crucial.
Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week
Marat Fudim, Husam M. Salah, Janarthanan Sathananthan, Mathieu Bernier, Manesh R. Patel
doi : 10.1016/j.jacc.2021.04.090
Volume 78, Issue 1, 6 July 2021, Pages 66-76
The lymphatic system is an integral part of the circulatory system and plays an important role in the volume homeostasis of the human body. The complex anatomy and physiology paired with a lack of simple diagnostic tools to study the lymphatic system have led to an underappreciation of the contribution of the lymphatic system to acute and chronic heart failure (HF).
The Tobacco Endgame: Eradicating a Worsening Epidemic A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology
Jeffrey Willett, Stephan Achenbach, Fausto J. Pinto, Athena Poppas, Mitchell S.V. Elkind
doi : 10.1016/j.jacc.2021.04.005
Volume 78, Issue 1, 6 July 2021, Pages 77-81
Becoming an Early-Career Inventor
Ahmed M.A. Selim, Chirag R. Barbhaiya
doi : 10.1016/j.jacc.2021.03.344
Volume 78, Issue 1, 6 July 2021, Pages 82-86
RESPONSE: Navigating a Career in Innovation
Paul Yock
doi : 10.1016/j.jacc.2021.03.345
Volume 78, Issue 1, 6 July 2021, Page 86
Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease: The ARIC Study
Yejin Mok, Shoshana H. Ballew, Richard Brandon Stacey, Joseph Rossi, Kunihiro Matsushita
doi : 10.1016/j.jacc.2021.04.089
Volume 78, Issue 1, 6 July 2021, Pages 87-89
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans
Senthil Selvaraj, Brian Claggett, Masatoshi Minamisawa, B. Gwen Windham, Scott D. Solomon
doi : 10.1016/j.jacc.2021.04.042
Volume 78, Issue 1, 6 July 2021, Pages 89-91
Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!
Edoardo Sciatti, Rossana Orabona
doi : 10.1016/j.jacc.2021.03.341
Volume 78, Issue 1, 6 July 2021, Page 91
Reply: Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!
Malamo E. Countouris, Flordeliza S. Villanueva, Janet M. Catov
doi : 10.1016/j.jacc.2021.04.069
Volume 78, Issue 1, 6 July 2021, Pages 91-92
